Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II

被引:41
作者
Feliers, D [1 ]
Duraisamy, S [1 ]
Barnes, JL [1 ]
Ghosh-Choudhury, G [1 ]
Kasinath, BS [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med Nephrol, S Texas Vet Hlth Care Syst, San Antonio, TX USA
关键词
protein expression; polysomes; nephropathy;
D O I
10.1152/ajprenal.00271.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am J Physiol Renal Physiol 288: F521-F529, 2005. First published November 30, 2004; doi:10.1152/ ajprenal.00271.2004.-ANG II regulates growth factor expression in the kidney. We investigated whether ANG II regulated vascular endothelial growth factor (VEGF) synthesis in proximal tubular epithelial (MCT) cells. ANG II (1 nM) increased VEGF protein expression within 5 min, the effect lasting for 30 min. There was no change in VEGF mRNA levels or mRNA stability, and transcription inhibitors did not affect ANG II-induced VEGF expression. Regulation of VEGF translation was investigated. Polyribosomal analysis revealed selective enrichment of heavy ribosomes (polysomes) with VEGF mRNA transcripts compared with light ribosomes in ANG II-treated cells, although distribution of GAPDH was unaltered. In vitro translation of total RNA from polysomal fractions showed selective increase in VEGF protein synthesis in ANG II-treated cells. Preincubation with LY-294002, a PI 3-kinase inhibitor, or expression of dominant-negative Akt prevented ANG II-stimulated increase in VEGF translation. ANG 11 increased phosphorylation of eukaryouic initiation factor 4E and its binding protein 4E-BP1, critical events that regulate the initiation phase of protein translation. ANG 11 failed to increase VEGF mRNA translation in cells stably expressing the phosphorylation mutant of 4E-BP1. Our data illustrate that a rapid increase in VEGF protein expression by ANG 11 is regulated at the initiation phase of translation of VEGF mRNA in renal epithelial cells. Regulation of VEGF translation by ANG 11 represents a novel pathway of renal response to injury.
引用
收藏
页码:F521 / F529
页数:9
相关论文
共 52 条
[1]   Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate [J].
Adamis, AP ;
Shima, DT ;
Tolentino, MJ ;
Gragoudas, ES ;
Ferrara, N ;
Folkman, J ;
DAmore, PA ;
Miller, JW .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) :66-71
[2]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[3]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[4]   Role of vascular endothelial growth factor in diabetic vascular complications [J].
Aiello, LP ;
Wong, JS .
KIDNEY INTERNATIONAL, 2000, 58 :S113-S119
[5]   Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription [J].
Akiri, G ;
Nahari, D ;
Finkelstein, Y ;
Le, SY ;
Elroy-Stein, O ;
Levi, BZ .
ONCOGENE, 1998, 17 (02) :227-236
[6]   Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells [J].
Bermont, L ;
Lamielle, F ;
Lorchel, F ;
Fauconnet, S ;
Esumi, H ;
Weisz, A ;
Adessi, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :363-368
[7]  
Bhandari BK, 2001, KIDNEY INT, V59, P866
[8]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[9]   Angiotensin II and its receptors in the diabetic kidney [J].
Burns, KD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :449-467
[10]  
De Vriese AS, 2001, J AM SOC NEPHROL, V12, P1734, DOI 10.1681/ASN.V1281734